Has Ramsey Saba, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,743 in general payments to Ramsey Saba, MD across 244 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ramsey Saba, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ramsey Saba, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ramsey Saba, MD

Anesthesiology · Fairfield, CTNPI 1093125601

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,038 of the $8,743 with a category attached, or 80.5%. It is spread thinly across 17 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,939 and has fallen 65.4% since, to $1,363 in 2025. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,743in general payments, 2019–2025

Across 244 payments — averaging $35.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vertiflex, Inc.$2K
Saluda Medical Americas, Inc.$2K
Nevro Corp.$2K
Abbott$1K
Boston Scientific$679
Medtronic$459
plus $2K from 11 others

What the payments were for

Travel & lodging$1,26214%
Food & beverage$7,03880%
Education$4445%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vertiflex, Inc.	11	$1,724
Saluda Medical Americas, Inc.	93	$1,630
Nevro Corp.	23	$1,552
Abbott	11	$1,070
Boston Scientific	18	$679
Medtronic(2 entities)	12	$459
Amgen	38	$354
Si-bone, Inc.	6	$331
Globus Medical	12	$326
Vertos Medical, Inc.	4	$190
Relievant Medsystems, Inc.	5	$164
Painteq LLC	5	$148
Biotronik NRO, Inc.	1	$37
Avanos Medical	1	$26
Bioventus LLC	2	$24
Stimwave Technologies Incorporated	1	$18
SPR Therapeutics, Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Superion ISS$1,448
Senza Spinal Cord Stimulation System$732
Axium INS DRG IPG$624
Evoke$365
Senza$336
GENERAL PAIN MANAGEMENT$271
Omnia$238
Proclaim Family of SCS IPGs$224
KYPHON Balloon Kyphoplasty$174
AUTOFILL$132
Octrode SCS Leads$126

How this compares

$8,743 in reported general payments places this provider in the 95th percentile of 664 anesthesiology providers in Connecticut.

See all anesthesiology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$427,407

Medicare patients

559

Services billed

11,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lidocaine	76	$5,683
Gabapentin	438	$4,947
Pregabalin	136	$2,933
Cyclobenzaprine Hcl	117	$1,990
Duloxetine Hcl	40	$935
Tramadol Hcl	222	$815
Diclofenac Sodium	14	$579
Methylprednisolone	79	$507
Tizanidine Hcl	55	$492
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	55	$484
Baclofen	35	$411
Celecoxib	25	$269
Memantine Hcl	14	$246
Methocarbamol	17	$222
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	23	$211

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Fairfield

Zeev KainNew Haven$273K
Alison ConsidineNew Haven$82K
Sanjay SinhaHartford$42K
William RosenblattNew Haven$40K
Paul HeerdtNew Haven$36K
Antonio PazBrookfield$27K
Honghui FengOld Saybrook$20K
Prakash PatelNew Haven$20K
Aymen AlianNew Haven$17K
Theresa BowlingShelton$10K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →